» Articles » PMID: 35230187

CT-based Radiogenomic Analysis of Clinical Stage I Lung Adenocarcinoma with Histopathologic Features and Oncologic Outcomes

Overview
Journal Radiology
Specialty Radiology
Date 2022 Mar 1
PMID 35230187
Authors
Affiliations
Soon will be listed here.
Abstract

Background A preoperative predictive model is needed that can be used to identify patients with lung adenocarcinoma (LUAD) who have a higher risk of recurrence or metastasis. Purpose To investigate associations between CT-based radiomic consensus clustering of stage I LUAD and clinical-pathologic features, genomic data, and patient outcomes. Materials and Methods Patients who underwent complete surgical resection for LUAD from April 2014 to December 2017 with preoperative CT and next-generation sequencing data were retrospectively identified. Comprehensive radiomic analysis was performed on preoperative CT images; tumors were classified as solid, ground glass, or mixed. Patients were clustered into groups based on their radiomics features using consensus clustering, and clusters were compared with tumor genomic alterations, histopathologic features, and recurrence-specific survival (Kruskal-Wallis test for continuous data, χ or Fisher exact test for categorical data, and log-rank test for recurrence-specific survival). Cluster analysis was performed on the entire cohort and on the solid, ground-glass, and mixed lesion subgroups. Results In total, 219 patients were included in the study (median age, 68 years; interquartile range, 63-74 years; 150 [68%] women). Four radiomic clusters were identified. Cluster 1 was associated with lepidic, acinar, and papillary subtypes (76 of 90 [84%]); clusters 2 (13 of 50 [26%]) and 4 (13 of 45 [29%]) were associated with solid and micropapillary subtypes ( < .001). The alterations were highest in cluster 1 (38 of 90 [42%], = .004). Clusters 2, 3, and 4 were associated with lymphovascular invasion (19 of 50 [38%], 14 of 34 [41%], and 28 of 45 [62%], respectively; < .001) and tumor spread through air spaces (32 of 50 [64%], 21 of 34 [62%], and 31 of 45 [69%], respectively; < .001). alterations (14 of 45 [31%]; = .006), phosphoinositide 3-kinase pathway alterations (22 of 45 [49%], < .001), and risk of recurrence (log-rank < .001) were highest in cluster 4. Conclusion CT-based radiomic consensus clustering enabled identification of associations between radiomic features and clinicalpathologic and genomic features and outcomes in patients with clinical stage I lung adenocarcinoma. © RSNA, 2022 See also the editorial by Nishino in this issue.

Citing Articles

Clinical Versus Pathological Staging in Patients with Resected Ground Glass Pulmonary Lesions.

Faber D, Agbarya A, Lee A, Tsenter Y, Schneer S, Robitsky Gelis Y Diagnostics (Basel). 2025; 14(24.

PMID: 39767235 PMC: 11675473. DOI: 10.3390/diagnostics14242874.


Radiomic Consensus Clustering in Glioblastoma and Association with Gene Expression Profiles.

Wroblewski T, Karabacak M, Seah C, Yong R, Margetis K Cancers (Basel). 2025; 16(24.

PMID: 39766155 PMC: 11674874. DOI: 10.3390/cancers16244256.


Predicting lymph node metastasis of clinical T1 non-small cell lung cancer: a brief review of possible methodologies and controversies.

Zhang L, Zhang F, Li G, Xiang X, Liang H, Zhang Y Front Oncol. 2024; 14:1422623.

PMID: 39720561 PMC: 11667114. DOI: 10.3389/fonc.2024.1422623.


From Images to Genes: Radiogenomics Based on Artificial Intelligence to Achieve Non-Invasive Precision Medicine in Cancer Patients.

Guo Y, Li T, Gong B, Hu Y, Wang S, Yang L Adv Sci (Weinh). 2024; 12(2):e2408069.

PMID: 39535476 PMC: 11727298. DOI: 10.1002/advs.202408069.


Pathomic and bioinformatics analysis of clinical-pathological and genomic factors for pancreatic cancer prognosis.

Li Y, Pan L, Mugaanyi J, Li H, Li G, Huang J Sci Rep. 2024; 14(1):27769.

PMID: 39533091 PMC: 11557977. DOI: 10.1038/s41598-024-79619-1.


References
1.
Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2008; 45(2):228-47. DOI: 10.1016/j.ejca.2008.10.026. View

2.
Chen L, Yang S, Wang H, Chen Y, Lin M, Hsieh M . Prediction of micropapillary and solid pattern in lung adenocarcinoma using radiomic values extracted from near-pure histopathological subtypes. Eur Radiol. 2021; 31(7):5127-5138. DOI: 10.1007/s00330-020-07570-6. View

3.
Xu Y, Lu L, E L, Lian W, Yang H, Schwartz L . Application of Radiomics in Predicting the Malignancy of Pulmonary Nodules in Different Sizes. AJR Am J Roentgenol. 2019; 213(6):1213-1220. DOI: 10.2214/AJR.19.21490. View

4.
von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007; 147(8):573-7. DOI: 10.7326/0003-4819-147-8-200710160-00010. View

5.
Kelsey I, Manning B . mTORC1 status dictates tumor response to targeted therapeutics. Sci Signal. 2013; 6(294):pe31. DOI: 10.1126/scisignal.2004632. View